MYGN

Myriad Genetics, Inc. provides genetic and genomic testing services that help patients and healthcare providers make informed healthcare decisions. The company specializes in hereditary cancer risk assessment, reproductive health, oncology, urology, and mental health, offering tests that identify genetic risks, inform treatment strategies, and support personalized healthcare. Myriad operates primarily in the United States, focusing on improving patient outcomes through actionable genetic insights and advanced testing solutions.